MyCelx Tech. Corp. MyCelx Tech. Corp.. - Director Shareholding

Mycelx Technologies

16/08/2019 15:02

RNS Number : 3857J

MyCelx Technologies Corporation

16 August 2019

 

 

16 August 2019

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

("MYCELX" or the "Company")

Director Shareholding

 

The Company announces that today, 16 August 2019, Non-Executive Chairman, Tim Eggar, and Chief Executive Officer, Connie Mixon purchased 8,182 and 450,000 shares, respectively, in the Company at a price of 55p per share.

Following this transaction, Tim Eggar holds 140,511, while Connie Mixon holds 1,457,703, ordinary shares in the Company, representing 0.72% and 7.50%, respectively, of the Company's issued share capital.

The Notification of Dealing Forms set out below is made in fulfilment of the obligation under Article 19 of the EU Market Abuse Regulation:

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Tim Eggar
2.
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification/Amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Mycelx Technologies Corporation
b)
LEI
213800UJZINIK2VD1G48
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of $0.025 each.

 ISIN - MYX.L = US62847T2024 (DI)
ISIN - MYXR.L = USU624551151 (REG S)
b)
Nature of the transaction:
Purchase of shares
c)
Price(s) and volume(s):
Price(s)
Volume(s)
55p
8,182
d)
Aggregated information:
· Aggregate volume
· Price
Aggregated volume:8,182
Price:55p
e)
Date of the transaction:
16August 2019
f)
Place of the transaction:
London Stock Exchange [XLON]

 

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Connie Mixon
2.
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification/Amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Mycelx Technologies Corporation
b)
LEI
213800UJZINIK2VD1G48
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of $0.025 each.

 ISIN - MYX.L = US62847T2024 (DI)
ISIN - MYXR.L = USU624551151 (REG S)
b)
Nature of the transaction:
Purchase of shares
c)
Price(s) and volume(s):
Price(s)
Volume(s)
55p
450,000
d)
Aggregated information:
· Aggregate volume
· Price
Aggregated volume:450,000
Price:55p
e)
Date of the transaction:
16August 2019
f)
Place of the transaction:
London Stock Exchange [XLON]

 

For further information please contact: 

MYCELX Technologies Corporation
Time Eggar, Non-Executive Chairman
Connie Mixon, CEO
Kim Slayton, CFO
Tel: +1 888 306 6843
Numis Securities Limited
John Prior
Alamgir Ahmed
James Black
Emily Morris
Tel: +44 20 7260 1000
Celicourt
Mark Antelme
Jimmy Lea
Tel: +44 20 8434 2754

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

END

 

 

DSHPFMJTMBABBRL